Absolute proof of efficacy can only be given by placebo controlled trials. It is, however, important to classify a drug within the spectrum of existing therapeutic alternatives and, where effective treatment is available, it may be imperative due to ethical considerations to demonstrate that one dru
β¦ LIBER β¦
Issues in assessing therapeutic equivalence
β Scribed by Salim Daya
- Book ID
- 117836728
- Publisher
- Elsevier Science
- Year
- 2001
- Tongue
- English
- Weight
- 68 KB
- Volume
- 3
- Category
- Article
- ISSN
- 1361-259X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Clinical and statistical issues in thera
β
E. Garbe; J. RΓΆhmel; U. Gundert-Remy
π
Article
π
1993
π
Springer
π
English
β 762 KB
A note on statistical methods for assess
β
Shein-Chung Chow; Jun Shao
π
Article
π
2002
π
Elsevier Science
π
English
β 70 KB
Therapeutic Equivalence β Clinical Issue
β
Axel Munk; Hans J. Trampisch
π
Article
π
2005
π
John Wiley and Sons
π
English
β 99 KB
π 2 views
Assessing ecological equivalence in biod
β
Fabien QuΓ©tier; Sandra Lavorel
π
Article
π
2011
π
Elsevier Science
π
English
β 489 KB
Practical issues in equivalence trials
β
A. F. Ebbutt; L. Frith
π
Article
π
1998
π
John Wiley and Sons
π
English
β 81 KB
π 2 views
Equivalence trials aim to show that two treatments have equivalent therapeutic effects. The approach is to define, in advance, a range of equivalence !d to#d for the treatment difference such that any value in the range is clinically unimportant. If the confidence interval for the difference, calcul
Method for assessing the duration of the
β
David V. Sheehan; Ashok B. Raj; K. Harnett-Sheehan; Jocelyn Dorotheo; Michael F.
π
Article
π
1996
π
John Wiley and Sons
π
English
β 716 KB